CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation

被引:177
作者
Kowarik, Markus C. [1 ]
Cepok, Sabine [1 ]
Sellner, Johann [1 ]
Grummel, Verena [1 ]
Weber, Martin S. [1 ]
Korn, Thomas [1 ]
Berthele, Achim [1 ]
Hemmer, Bernhard [1 ]
机构
[1] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-8000 Munich, Germany
来源
JOURNAL OF NEUROINFLAMMATION | 2012年 / 9卷
关键词
CCL19; CCL21; CXCL12; CXCL13; BAFF; APRIL; B cells and plasmablasts; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS LESIONS; CEREBROSPINAL-FLUID; CHEMOKINE CXCL13; LYME NEUROBORRELIOSIS; BAFF; EXPRESSION; LIGAND; ASTROCYTES; RECEPTORS;
D O I
10.1186/1742-2094-9-93
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: The chemokines and cytokines CXCL13, CXCL12, CCL19, CCL21, BAFF and APRIL are believed to play a role in the recruitment of B cells to the central nervous system (CNS) compartment during neuroinflammation. To determine which chemokines/cytokines show the strongest association with a humoral immune response in the cerebrospinal fluid (CSF), we measured their concentrations in the CSF and correlated them with immune cell subsets and antibody levels. Methods: Cytokine/chemokine concentrations were measured in CSF and serum by ELISA in patients with noninflammatory neurological diseases (NIND, n = 20), clinically isolated syndrome (CIS, n = 30), multiple sclerosis (MS, n = 20), Lyme neuroborreliosis (LNB, n = 8) and patients with other inflammatory neurological diseases (OIND, n = 30). Albumin, IgG, IgA and IgM were measured by nephelometry. CSF immune cell subsets were determined by seven-color flow cytometry. Results: CXCL13 was significantly elevated in the CSF of all patient groups with inflammatory diseases. BAFF levels were significantly increased in patients with LNB and OIND. CXCL12 was significantly elevated in patients with LNB. B cells and plasmablasts were significantly elevated in the CSF of all patients with inflammatory diseases. CXCL13 showed the most consistent correlation with CSF B cells, plasmablasts and intrathecal Ig synthesis. Conclusions: CXCL13 seems to be the major determinant for B cell recruitment to the CNS compartment in different neuroinflammatory diseases. Thus, elevated CSF CXCL13 levels rather reflect a strong humoral immune response in the CNS compartment than being specific for a particular disease entity.
引用
收藏
页数:11
相关论文
共 31 条
[21]   A prospective study on the role of CXCL13 in Lyme neuroborreliosis [J].
Schmidt, C. ;
Plate, A. ;
Angele, B. ;
Pfister, H. -W. ;
Wick, M. ;
Koedel, U. ;
Rupprecht, T. A. .
NEUROLOGY, 2011, 76 (12) :1051-1058
[22]   BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth [J].
Schneider, P ;
MacKay, F ;
Steiner, V ;
Hofmann, K ;
Bodmer, JL ;
Holler, N ;
Ambrose, C ;
Lawton, P ;
Bixler, S ;
Acha-Orbea, H ;
Valmori, D ;
Romero, P ;
Werner-Favre, C ;
Zubler, RH ;
Browning, JL ;
Tschopp, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (11) :1747-1756
[23]   Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS [J].
Sellebjerg, F. ;
Bornsen, L. ;
Khademi, M. ;
Krakauer, M. ;
Olsson, T. ;
Frederiksen, J. L. ;
Sorensen, P. S. .
NEUROLOGY, 2009, 73 (23) :2003-2010
[24]   The chemokine CXCL13 in acute neuroborreliosis [J].
Senel, Makbule ;
Rupprecht, Tobias A. ;
Tumani, Hayrettin ;
Pfister, Hans W. ;
Ludolph, Albert C. ;
Brettschneider, Johannes .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (08) :929-933
[25]   Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis [J].
Serafini, B ;
Rosicarelli, B ;
Magliozzi, R ;
Stigliano, E ;
Aloisi, F .
BRAIN PATHOLOGY, 2004, 14 (02) :164-174
[26]   A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking [J].
Teunissen, C. E. ;
Petzold, A. ;
Bennett, J. L. ;
Berven, F. S. ;
Brundin, L. ;
Comabella, M. ;
Franciotta, D. ;
Frederiksen, J. L. ;
Fleming, J. O. ;
Furlan, R. ;
Hintzen, R. Q. ;
Hughes, S. G. ;
Johnson, M. H. ;
Krasulova, E. ;
Kuhle, J. ;
Magnone, M. C. ;
Rajda, C. ;
Rejdak, K. ;
Schmidt, H. K. ;
van Pesch, V. ;
Waubant, E. ;
Wolf, C. ;
Giovannoni, G. ;
Hemmer, B. ;
Tumani, H. ;
Deisenhammer, F. .
NEUROLOGY, 2009, 73 (22) :1914-1922
[27]   A proliferation-inducing ligand (APRIL) is expressed by astrocytes and is increased in multiple sclerosis [J].
Thangarajh, M. ;
Masterman, T. ;
Hillert, J. ;
Moerk, S. ;
Jonsson, R. .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2007, 65 (01) :92-98
[28]   Increased levels of APRIL (a proliferation-inducing ligand) mRNA in multiple sclerosis [J].
Thangarajh, M ;
Masterman, T ;
Rot, U ;
Duvefelt, K ;
Brynedal, B ;
Karrenbauer, VD ;
Hillert, J .
JOURNAL OF NEUROIMMUNOLOGY, 2005, 167 (1-2) :210-214
[29]   Expression of B-cell-activating factor of the TNF family (BAFF) and its receptors in multiple sclerosis [J].
Thangarajh, M ;
Gomes, A ;
Masterman, T ;
Hillert, J ;
Hjelmström, P .
JOURNAL OF NEUROIMMUNOLOGY, 2004, 152 (1-2) :183-190
[30]   Discriminating Lyme Neuroborreliosis from Other Neuroinflammatory Diseases by Levels of CXCL13 in Cerebrospinal Fluid [J].
van Burgel, N. D. ;
Bakels, F. ;
Kroes, A. C. M. ;
van Dam, A. P. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (05) :2027-2030